Silkworm model of biofilm formation: In vivo evaluation of antimicrobial tolerance of a cross-kingdom dual-species (Escherichia coli and Candida albicans) biofilm on catheter material
暂无分享,去创建一个
[1] T. Sugita,et al. Candida albicans Promotes the Antimicrobial Tolerance of Escherichia coli in a Cross-Kingdom Dual-Species Biofilm , 2022, Microorganisms.
[2] C. Cho,et al. Progress of Polysaccharide-Contained Polyurethanes for Biomedical Applications , 2022, Tissue Engineering and Regenerative Medicine.
[3] A. Raghu,et al. A microplate‐based Response Surface Methodology model for growth optimization and biofilm formation on polystyrene polymeric material in a Candida albicans and Escherichia coli co‐culture , 2022, Polymers for Advanced Technologies.
[4] K. Shetty,et al. Polymicrobial Biofilm Dynamics of Multidrug-Resistant Candida albicans and Ampicillin-Resistant Escherichia coli and Antimicrobial Inhibition by Aqueous Garlic Extract , 2022, Antibiotics.
[5] I. Dag,et al. In vitro effect of farnesol on planktonic cells and dual biofilm formed by Candida albicans and Escherichia coli , 2022, Biofouling.
[6] K. Shetty,et al. High throughput comparative assessment of biofilm formation of Candida glabrata on polystyrene material , 2022, Korean Journal of Chemical Engineering.
[7] K. Shetty,et al. Candida albicans biofilm formation and growth optimization for functional studies using response surface methodology , 2021, Journal of applied microbiology.
[8] E. D. Di Domenico,et al. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection , 2021, Microbiology spectrum.
[9] T. Sugita,et al. Pharmacokinetics of voriconazole and its alteration by Candida albicans infection in silkworms , 2021, The Journal of Antibiotics.
[10] J. Naglik,et al. Candida albicans biofilms and polymicrobial interactions , 2021, Critical reviews in microbiology.
[11] G. Maisetta,et al. Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections , 2021, International journal of molecular sciences.
[12] T. Sugita,et al. Evaluating Candida albicans biofilm formation in silkworms. , 2020, Medical mycology.
[13] C. Kaito,et al. Animal infection models using non‐mammals , 2020, Microbiology and immunology.
[14] E. Denamur,et al. Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it. , 2020, The Journal of antimicrobial chemotherapy.
[15] S. Auparakkitanon,et al. Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial , 2020, Journal of Intensive Care.
[16] Yasuhiko Matsumoto. Facilitating Drug Discovery in Human Disease Models Using Insects. , 2020, Biological & pharmaceutical bulletin.
[17] R. Hall,et al. Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm , 2019, The Journal of antimicrobial chemotherapy.
[18] K. Sekimizu,et al. Pharmacokinetics of anti-infectious reagents in silkworms , 2019, Scientific Reports.
[19] K. Sekimizu,et al. Silkworm as an experimental animal for research on fungal infections , 2019, Microbiology and immunology.
[20] M. Ghannoum,et al. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms , 2018, Microbial cell.
[21] Peter Belenky,et al. Microbial competition between Escherichia coli and Candida albicans reveals a soluble fungicidal factor , 2018, Microbial cell.
[22] K. Sekimizu,et al. Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model , 2018, Scientific Reports.
[23] J. Nett,et al. The Interface between Fungal Biofilms and Innate Immunity , 2018, Front. Immunol..
[24] F. Contaldo,et al. Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome. , 2016, Clinical nutrition.
[25] P. van Dijck,et al. Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix , 2016, mBio.
[26] K. Sekimizu,et al. Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection , 2016, The Journal of Antibiotics.
[27] D. Soll,et al. Plasticity of Candida albicans Biofilms , 2016, Microbiology and Molecular Reviews.
[28] J. Nett. The Host’s Reply to Candida Biofilm , 2016, Pathogens.
[29] K. Sekimizu,et al. Acute oral toxicity test of chemical compounds in silkworms. , 2016, Drug discoveries & therapeutics.
[30] M. Doble,et al. Bacterial resistance in biofilm-associated bacteria. , 2015, Future microbiology.
[31] E. Mylonakis,et al. Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology , 2015, Antimicrobial Agents and Chemotherapy.
[32] J. Bernhardt,et al. Host Contributions to Construction of Three Device-Associated Candida albicans Biofilms , 2015, Infection and Immunity.
[33] Yue Zheng,et al. Biofilm formation mechanisms and targets for developing antibiofilm agents. , 2015, Future medicinal chemistry.
[34] J. Chander,et al. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections - A prospective study from a tertiary care hospital , 2015, Indian journal of medical microbiology.
[35] N. Verstraeten,et al. Fungal β-1,3-Glucan Increases Ofloxacin Tolerance of Escherichia coli in a Polymicrobial E. coli/Candida albicans Biofilm , 2015, Antimicrobial Agents and Chemotherapy.
[36] H. Kurihara,et al. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. , 2015, Nature chemical biology.
[37] David Lebeaux,et al. Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics , 2014, Microbiology and Molecular Reviews.
[38] A. Walker,et al. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011. , 2012, The Journal of antimicrobial chemotherapy.
[39] E. Denamur,et al. Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia , 2010, Journal of Clinical Microbiology.
[40] H. Flemming,et al. The biofilm matrix , 2010, Nature Reviews Microbiology.
[41] P. Lipke,et al. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. , 2007, Diagnostic microbiology and infectious disease.
[42] M. Ghannoum,et al. Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy , 2004, Antimicrobial Agents and Chemotherapy.
[43] H. Kusuhara,et al. Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic Microorganisms , 2004, Antimicrobial Agents and Chemotherapy.
[44] D. Davies,et al. Understanding biofilm resistance to antibacterial agents , 2003, Nature Reviews Drug Discovery.
[45] R. Donlan,et al. Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.
[46] Haruo Watanabe,et al. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. , 2002, Microbial pathogenesis.
[47] N. Khardori,et al. Biofilms in device-related infections , 1995, Journal of Industrial Microbiology.
[48] G. O’Toole,et al. Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.
[49] N. Webber,et al. Association between atherosclerosis and osteoporosis, the role of vitamin D , 2011, Archives of medical science : AMS.